New breakthrough Alzheimer’s drug gets unanimous backing from FDA advisors – New York Post

New breakthrough Alzheimer’s drug gets unanimous backing from FDA advisors New York Post FDA advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, paving way for approval CNBCFDA panel votes unanimously for Eli Lilly’s Alzheimer’s treatment Yahoo FinanceAlzheimer’s drug with modest benefits wins backing of FDA advisers Nature.com